These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 18063001
1. Impaired synaptogenesis and long-term modulation of behavior following postnatal elevation of GABA levels in mice. Levav T, Wirthaim O, Weiss R, Grossman Y, Golan H. Neuropharmacology; 2008 Feb; 54(2):387-98. PubMed ID: 18063001 [Abstract] [Full Text] [Related]
2. Long-lasting glutamatergic modulation induced by neonatal GABA enhancement in mice. Melamed O, Levav-Rabkin T, Zukerman C, Clarke G, Cryan JF, Dinan TG, Grossman Y, Golan HM. Neuropharmacology; 2014 Apr; 79():616-25. PubMed ID: 24462620 [Abstract] [Full Text] [Related]
3. A sensitive period of mice inhibitory system to neonatal GABA enhancement by vigabatrin is brain region dependent. Levav-Rabkin T, Melamed O, Clarke G, Farber M, Cryan JF, Dinan TG, Grossman Y, Golan HM. Neuropsychopharmacology; 2010 Apr; 35(5):1138-54. PubMed ID: 20043003 [Abstract] [Full Text] [Related]
4. Sex-dependent behavioral effects of Mthfr deficiency and neonatal GABA potentiation in mice. Levav-Rabkin T, Blumkin E, Galron D, Golan HM. Behav Brain Res; 2011 Jan 20; 216(2):505-13. PubMed ID: 20813139 [Abstract] [Full Text] [Related]
5. Neonatal ketamine exposure results in changes in biochemical substrates of neuronal growth and synaptogenesis, and alters adult behavior irreversibly. Viberg H, Pontén E, Eriksson P, Gordh T, Fredriksson A. Toxicology; 2008 Jul 30; 249(2-3):153-9. PubMed ID: 18550250 [Abstract] [Full Text] [Related]
6. Distinct expression and distribution of vesicular proteins in the hippocampus of TNFa-deficient mice during development. Golan H, Levav T, Huleihel M. Synapse; 2004 Jul 30; 53(1):6-10. PubMed ID: 15150735 [Abstract] [Full Text] [Related]
7. The effects of chronic administration of ethosuximide on learning and memory: a behavioral and biochemical study on nonepileptic rats. Ponnusamy R, Pradhan N. Behav Pharmacol; 2006 Nov 30; 17(7):573-80. PubMed ID: 17021389 [Abstract] [Full Text] [Related]
8. Effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl GABA and ethanolamine O-sulphate on the in vitro GABA release from rat hippocampus. Qume M, Fowler LJ. Br J Pharmacol; 1997 Oct 30; 122(3):539-45. PubMed ID: 9351512 [Abstract] [Full Text] [Related]
9. Fetal exposure to GABA-acting antiepileptic drugs generates hippocampal and cortical dysplasias. Manent JB, Jorquera I, Mazzucchelli I, Depaulis A, Perucca E, Ben-Ari Y, Represa A. Epilepsia; 2007 Apr 30; 48(4):684-93. PubMed ID: 17437411 [Abstract] [Full Text] [Related]
10. Trimethyltin-induced alterations in behavior are linked to changes in PSA-NCAM expression. Halladay AK, Wilson DT, Wagner GC, Reuhl KR. Neurotoxicology; 2006 Mar 30; 27(2):137-46. PubMed ID: 16426681 [Abstract] [Full Text] [Related]
11. Glutamatergic synapse protein composition of wild-type mice is sensitive to in utero MTHFR genotype and the timing of neonatal vigabatrin exposure. Zuckerman C, Blumkin E, Melamed O, Golan HM. Eur Neuropsychopharmacol; 2015 Oct 30; 25(10):1787-802. PubMed ID: 26235956 [Abstract] [Full Text] [Related]
13. Synapsin-dependent development of glutamatergic synaptic vesicles and presynaptic plasticity in postnatal mouse brain. Bogen IL, Jensen V, Hvalby O, Walaas SI. Neuroscience; 2009 Jan 12; 158(1):231-41. PubMed ID: 18606212 [Abstract] [Full Text] [Related]
14. GABA homeostasis contributes to the developmental programming of anxiety-related behavior. Depino AM, Tsetsenis T, Gross C. Brain Res; 2008 May 19; 1210():189-99. PubMed ID: 18407251 [Abstract] [Full Text] [Related]
15. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM. Neuropharmacology; 2008 Nov 19; 55(6):1006-14. PubMed ID: 18761360 [Abstract] [Full Text] [Related]
16. Memantine treatment reduces the expression of the K(+)/Cl(-) cotransporter KCC2 in the hippocampus and cerebral cortex, and attenuates behavioural responses mediated by GABA(A) receptor activation in mice. Molinaro G, Battaglia G, Riozzi B, Di Menna L, Rampello L, Bruno V, Nicoletti F. Brain Res; 2009 Apr 10; 1265():75-9. PubMed ID: 19236854 [Abstract] [Full Text] [Related]
17. Long-term effects of diazepam treatment of epileptic GABAA receptor beta3 subunit knockout mouse in early life. Liljelund P, Ferguson C, Homanics G, Olsen RW. Epilepsy Res; 2005 Apr 10; 66(1-3):99-115. PubMed ID: 16168624 [Abstract] [Full Text] [Related]
18. Acute sublethal global hypoxia induces transient increase of GAP-43 immunoreactivity in the striatum of neonatal rats. Valdez SR, Patterson SI, Ezquer ME, Torrecilla M, Lama MC, Seltzer AM. Synapse; 2007 Mar 10; 61(3):124-37. PubMed ID: 17146769 [Abstract] [Full Text] [Related]
20. Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation. Yamamoto Y, Shioda N, Han F, Moriguchi S, Nakajima A, Yokosuka A, Mimaki Y, Sashida Y, Yamakuni T, Ohizumi Y, Fukunaga K. Brain Res; 2009 Oct 27; 1295():218-29. PubMed ID: 19646972 [Abstract] [Full Text] [Related] Page: [Next] [New Search]